AN2 Therapeutics, Inc.ANTXNASDAQ
Loading
Year-over-year net income growth rate
5Y CAGR
-12.0%/yr
Long-term compound
Percentile
P83
Within normal range
vs 5Y Ago
0.5x
Contraction
Streak
3 yr
Consecutive growthAccelerating
| Period | Value |
|---|---|
| 2025 | 31.46% |
| 2024 | 20.72% |
| 2023 | -58.05% |
| 2022 | -90.11% |
| 2021 | -58.37% |
| 2020 | 59.77% |
| 2019 | 0.00% |